变革生物制药制造业：礼来公司利用 Databricks 实现数据驱动之旅.pdf

1、Transforming Bio-PharmaManufacturing:Eli Lillys Data-Driven Journey With Databricks q 2 2WILFRED MASCARENHAS Executive Director Innovation and StrategyYOUR SPEAKERS TODAYSAUNAK DEBROYAssociate Director Lead Innovation ArchitectABHIJAY DATTAVice President Head of Delivery,Healthcare and Life Sciences

2、AGENDAAbout Lilly and Data JourneyArchitecture and ApproachKey LearningsUse Case Highlights,Demo and Whats Next!3About Eli Lilly and CompanyOur Purpose+ValuesLilly unites caring with discovery to create medicines that make life better for people around the world.OUR VALUESIntegrityExcellenceRespect

3、for PeopleAbout LillyGlobal Fast FactsClinical research conducted in more than 55 countriesResearch and development facilities located in 8 countriesManufacturing plants located in 9 countriesProducts marketed in approximately 105 countriesMore than 46,000 employees worldwideApproximately 11,000 emp

4、loyees engaged in research and developmentHeadquarters located in Indianapolis,Indiana,U.S.A.A heritage 149 years strong,founded on May 10,1876About LillyOur Strategy3MOLECULES AND INDICATIONS IN REGULATORY REVIEWOur fundamental strategy is predicated on discovering new medicines.Lilly currently has

5、 one of the most robust mid-to-late-stage pipelines in its history.*Numbers updated February 4,202522MOLECULES AND INDICATIONS IN PHASE 3 CLINICAL DEVELOPMENT24MOLECULES AND INDICATIONS IN PHASE 2 TESTING26MOLECULES AND INDICATIONS IN PHASE 1 TESTINGData JourneyCentralized GMP Validated Lakehouse(FA

6、IR Principles)Data WarehouseReportsData LakeUnstructured DataHigh Performance ApplianceDashboardsSelf-ServiceAnalyticsLakehouseData ProductsAI&Chat-BI2023201520102005Harmonized Application Stack Across All SitesGlobal GMP Validated Analytics Data-StoreOrg StructureAI Ready Data ProductsInnovation an